|
SocialPicks Sentiment:
N/A
** not enough data to be rated
|
This Quarter's Sentiment:
|
|
|
SocialPicks Community
Big Pharma Goes Generic
LCI
|
|
|
+23.85%
in
255 days
<> <> <> <> <> <>  Sanofi-Aventis (SNY) is now the 11 th largest generic drug maker in the world following its successful acquisition of Czech generic drug company Zentiva. As $70B in brand drug patents are set to expire through 2012, big pharma companies are hedging their bets through generic drug divisions, including Pfizer (PFE) - Greenstone, Novartis (NVS) - Sandoz, and the recently announced Merck (MRK) BioVent...
|
Generic Cardio Drugs Equal Brands - JAMA
LCI
|
|
|
+181.08%
in
85 days
(closed on 02/26/09)
<> 
A meta-analysis review of clinical studies published in peer-reviewed journals was featured today in The Journal of the American Medical Association [JAMA] and concluded that cost-saving generics used to treat a variety of cardiovascular conditions produced equivalent clinical outcomes to higher cost brand name drugs. Despite this clinical evidence, the review notes that a majority (53%) of the 43 editorials analyzed had a negative opinion on generic substitution.
While there are currently no ETFs on the market w...
|
Bullish on LCI ...
LCI
|
|
|
+30.42%
in
36 days
(closed on 05/04/08)
Lannett Company Receives FDA Approval for Bethanechol Chloride Tablets USP, 5 mg, 10 mg, 25 mg, and 50 mg
|
From the Blogosphere
Big Pharma Goes Generic
|
|
|
Sanofi-Aventis (SNY) is now the 11th largest generic drug maker in the world following its successful acquisition of Czech generic drug company Zentiva. As $70B in brand drug patents are set to expire through 2012, big pharma companies are hedging their bets through generic drug divisions, including Pfizer (PFE) - Greenstone, Novartis (NVS) - Sandoz, and the recently announced Merck (MRK) BioVentures which will specialize in bio-generics.
Elsewhere in the industry, India-based Ranbaxy (RANBAXY.NS) lost about 20% of its market value today on word the FDA would not review new generic drug prod...
|
A 130/30 Pharma Trade
|
|
|
<>The accompanying tables (click to enlarge either) include 12 U.S. listed companies from the ETF Innovators Global Generic Drug Index along with eight brand drug companies, which are ranked in descending order based on their patent expiration exposure through the end of 2011 as a percentage of total trailing 12-month revenue.
Investors who are bullish on the generic drug industry may consider implementing a 130/30 pharma trade by shorting any/all of the top seven brand drug companies by patent expiration exposure with 30% of their assets while investing 130% of assets in long positions among ...
|
Wednesday's 52 Week low's
|
|
|
SBUX Starbucks Corp 20.04
SAVB The Savannah Bancorp Inc 19.25
S Sprint Nextel Corporation 13.50
RL Polo Ralph Lauren Corp 63.12
M Macy's, Inc. 26.67
LCI Lannett Company Inc 3.27
KSS Kohl's Corporation 45.70
IHP IHOP Corp 38.22
IHG Intercontinental Htls ... 17.54
DD E.I. du Pont de Nemou ... 42.69
DBD Diebold, Incorporated 30.82
Donate to the ValuePlays Project for KIVA
 Subscribe in a reader
|
Wednesday's 52 Week low's
SBUX Starbucks Corp 20.04
SAVB The Savannah Bancorp Inc 19.25
S Sprint Nextel Corporation 13.50
RL Polo Ralph Lauren Corp 63.12
M Macy's, Inc. 26.67
LCI Lannett Company Inc 3.27
KSS Kohl's Corporation 45.70
IHP IHOP Corp 38.22
IHG Intercontinental Htls ... 17.54
DD E.I. du Pont de Nemou ... 42.69
DBD Diebold, Incorporated 30.82
Donate to the ValuePlays Project for KIVA
Subscribe in a reader
|
|
ROCK-STAR INVESTORS
|
|
POPULAR STOCKS
|
|
TODAY'S HEADLINES
|
|
TODAY'S TOP PICKS
|
|
|
Visit streetinsider.com
Be the first to start a discussion and earn 2 points.
More Resources
|
About Lannett Company Inc
- Answers.com
